AK
NASDAQ · AKAN
Akanda Corp.
Healthcare · Drug Manufacturers - Specialty & Generic
$3.86
Down-$0.04 (-1.03%)
Updated Aug 23, 2026, 11:22 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 151.47K
- P/E ratio
- -0.19
- Dividend yield
- 0.00%
- 52-week range
- $2.30 – $209.03
- Volume
- 164.81K
- Avg. volume
- 1.36M
Price performance
AKAN price history
1M range · 20 trading sessions · Daily adjusted prices
AKAN closed at $3.86 after 20 trading sessions, down 38.83% for the selected period.
- Last close
- $3.86
- Period change
- -38.83%
- Period low
- $3.86
- Period high
- $6.45
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $3.96 | $4.00 | $3.77 | $3.86 | 164.81K |
| Aug 20, 2026 | $3.98 | $4.0299 | $3.85 | $3.90 | 154.79K |
| Aug 19, 2026 | $4.44 | $4.46 | $3.97 | $4.06 | 361.91K |
| Aug 18, 2026 | $5.07 | $5.3074 | $4.7288 | $4.86 | 485.65K |
| Aug 17, 2026 | $5.28 | $5.46 | $4.99 | $5.41 | 1.03M |
| Aug 14, 2026 | $7.81 | $8.65 | $6.2251 | $6.45 | 14.04M |
| Aug 13, 2026 | $5.38 | $5.45 | $5.01 | $5.01 | 10.67M |
| Aug 12, 2026 | $5.26 | $5.46 | $5.0175 | $5.39 | 40.62K |
| Aug 11, 2026 | $5.03 | $5.2799 | $4.51 | $5.21 | 377.99K |
| Aug 10, 2026 | $5.14 | $5.32 | $4.96 | $5.01 | 27.83K |
| Aug 7, 2026 | $5.28 | $5.42 | $5.06 | $5.13 | 22.63K |
| Aug 6, 2026 | $5.24 | $5.38 | $5.1214 | $5.36 | 21.91K |
| Aug 5, 2026 | $5.30 | $5.545 | $5.00 | $5.03 | 51.8K |
| Aug 4, 2026 | $5.59 | $5.59 | $5.16 | $5.16 | 24.63K |
| Aug 3, 2026 | $5.55 | $5.69 | $5.2501 | $5.39 | 19.05K |
| Jul 31, 2026 | $6.08 | $6.12 | $5.14 | $5.31 | 89.94K |
| Jul 30, 2026 | $6.46 | $6.63 | $5.89 | $6.39 | 89.42K |
| Jul 29, 2026 | $6.02 | $7.42 | $5.76 | $5.78 | 145.5K |
| Jul 28, 2026 | $5.83 | $6.5599 | $5.75 | $6.20 | 66.21K |
| Jul 27, 2026 | $6.45 | $6.50 | $5.55 | $6.31 | 222.74K |
Latest AKAN news
The latest Smart Investors Daily articles mentioning AKAN.
Stock researchResearch & News · Analysis
Loading stock research…
